Paul Toren

Université Laval, Hôtel-Dieu de Québec

Papers

2

Total Citations

6

H-Index

2

About

Dr. Paul Toren is a urologic oncologist whose research focuses on optimizing perioperative care and mitigating opioid-related harms in uro-oncologic surgery. His work addresses the critical intersection of surgical recovery, pain management, and public health, particularly in the context of the ongoing opioid crisis. In a notable prospective study, Dr. Toren evaluated opioid prescribing patterns after uro-oncologic procedures, highlighting how a lack of standardized guidelines contributes to overprescription and potential patient harm. This work, cited 3 times, underscores his commitment to evidence-based, safer surgical practices. He has also investigated the effects of common dietary supplements on surgical outcomes, examining whether omega-3 fatty acid supplementation influences blood loss and complications during radical prostatectomy. By challenging routine preoperative discontinuation of these supplements, his research (3 citations) provides clinically relevant insights that balance potential benefits with surgical safety. Dr. Toren’s contributions are shaping more thoughtful, patient-centered protocols in urologic oncology, directly impacting recovery quality and reducing unnecessary risks.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Opioids use after uro-oncologic surgeries in time of opioid crisis
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Université Laval, Hôtel-Dieu de Québec

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago